- Home
- SONO vs LMAT Comparison
SONO vs LMAT Comparison
Compare SONO & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONO
- LMAT
- Stock Information
- Founded
- SONO 2002
- LMAT 1983
- Country
- SONO United States
- LMAT United States
- Employees
- SONO N/A
- LMAT N/A
- Industry
- SONO Consumer Electronics/Video Chains
- LMAT Medical/Dental Instruments
- Sector
- SONO Consumer Discretionary
- LMAT Health Care
- Exchange
- SONO Nasdaq
- LMAT Nasdaq
- Market Cap
- SONO 1.4B
- LMAT 2.0B
- IPO Year
- SONO 2018
- LMAT 2006
- Fundamental
- Price
- SONO $12.96
- LMAT $89.08
- Analyst Decision
- SONO Hold
- LMAT Buy
- Analyst Count
- SONO 3
- LMAT 6
- Target Price
- SONO $15.67
- LMAT $92.60
- AVG Volume (30 Days)
- SONO 1.3M
- LMAT 98.3K
- Earning Date
- SONO 11-13-2024
- LMAT 10-31-2024
- Dividend Yield
- SONO N/A
- LMAT 0.72%
- EPS Growth
- SONO N/A
- LMAT 47.83
- EPS
- SONO N/A
- LMAT 1.67
- Revenue
- SONO $1,567,823,000.00
- LMAT $205,621,000.00
- Revenue This Year
- SONO N/A
- LMAT $15.01
- Revenue Next Year
- SONO N/A
- LMAT $9.07
- P/E Ratio
- SONO N/A
- LMAT $54.11
- Revenue Growth
- SONO N/A
- LMAT 16.06
- 52 Week Low
- SONO $10.10
- LMAT $45.96
- 52 Week High
- SONO $19.76
- LMAT $93.32
- Technical
- Relative Strength Index (RSI)
- SONO 60.67
- LMAT 55.00
- Support Level
- SONO $12.76
- LMAT $84.69
- Resistance Level
- SONO $13.19
- LMAT $92.84
- Average True Range (ATR)
- SONO 0.36
- LMAT 2.05
- MACD
- SONO 0.06
- LMAT -0.07
- Stochastic Oscillator
- SONO 93.84
- LMAT 75.21
About SONO Sonos Inc.
Sonos Inc is engaged in providing home sound systems. The company's product profile includes speaker sets and other accessories like boost, mounts, stands, and cables and networking. Geographically, the company operates in the Americas, Europe, the Middle East and Africa, and the Asia Pacific. Generating a majority of its revenue from the Americas.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.